FI962056A - Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan - Google Patents

Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan Download PDF

Info

Publication number
FI962056A
FI962056A FI962056A FI962056A FI962056A FI 962056 A FI962056 A FI 962056A FI 962056 A FI962056 A FI 962056A FI 962056 A FI962056 A FI 962056A FI 962056 A FI962056 A FI 962056A
Authority
FI
Finland
Prior art keywords
acetylsalicylic acid
pharmaceutical composition
powder containing
methoclopramide
manufacture
Prior art date
Application number
FI962056A
Other languages
English (en)
Swedish (sv)
Other versions
FI116883B (fi
FI962056A0 (fi
Inventor
Nicole Bru
Jean-Francois Cordoliani
Pierre-Andre Poly
Jehan-Yves Drouin
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of FI962056A publication Critical patent/FI962056A/fi
Publication of FI962056A0 publication Critical patent/FI962056A0/fi
Application granted granted Critical
Publication of FI116883B publication Critical patent/FI116883B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962056A 1993-11-26 1996-05-15 Menetelmä jauhemuodossa olevan valmisteen valmistamiseksi FI116883B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9314170A FR2712809B1 (fr) 1993-11-26 1993-11-26 Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
FR9314170 1993-11-26
PCT/FR1994/001374 WO1995014462A1 (fr) 1993-11-26 1994-11-25 Nouvelle composition pharmaceutique destinee a la preparation d'une poudre stable contenant, a titre d'ingredient actif, une association d'acide acetylsalicylique et de metoclopramide
FR9401374 1994-11-25

Publications (3)

Publication Number Publication Date
FI962056A true FI962056A (fi) 1996-05-15
FI962056A0 FI962056A0 (fi) 1996-05-15
FI116883B FI116883B (fi) 2006-03-31

Family

ID=9453264

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962056A FI116883B (fi) 1993-11-26 1996-05-15 Menetelmä jauhemuodossa olevan valmisteen valmistamiseksi

Country Status (25)

Country Link
US (1) US5437874A (fi)
EP (1) EP0693926B1 (fi)
JP (1) JP3195356B2 (fi)
KR (1) KR100351193B1 (fi)
CN (1) CN1083260C (fi)
AT (1) ATE147623T1 (fi)
AU (1) AU693137B2 (fi)
CA (1) CA2175470C (fi)
CZ (1) CZ287757B6 (fi)
DE (1) DE69401502T2 (fi)
DK (1) DK0693926T3 (fi)
ES (1) ES2099649T3 (fi)
FI (1) FI116883B (fi)
FR (1) FR2712809B1 (fi)
GR (1) GR3023074T3 (fi)
HU (1) HU226895B1 (fi)
LV (1) LV11818B (fi)
NO (1) NO309024B1 (fi)
NZ (1) NZ276740A (fi)
RU (1) RU2146518C1 (fi)
SI (1) SI0693926T1 (fi)
SK (1) SK278986B6 (fi)
TW (1) TW372193B (fi)
UA (1) UA40636C2 (fi)
WO (1) WO1995014462A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol
US6376550B1 (en) * 1999-02-09 2002-04-23 Asta Medica Ag Pharmaceutical compositions containing tramadol for migraine
US6596708B1 (en) 2001-09-07 2003-07-22 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
EP1736156A4 (en) * 2004-04-15 2010-06-16 Eisai R&D Man Co Ltd COMPOSITION CONTAINING 4-AMINO-5-CHLORO-N-¬ (1R, 3R, 5S) -8-METHYL-8-AZABICYCLO-3.2.1 OCT-3-YL-2-β-methyl-2-ynyloxy BENZAMIDE STABILIZED
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
KR102397334B1 (ko) * 2016-06-28 2022-05-11 아사메딕 에이에스 2성분 조성물
CN113354553B (zh) * 2021-06-03 2023-09-15 北京宝诺康医药科技有限公司 一种甲氧氯普胺单盐酸盐一水合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380540A (en) * 1978-11-14 1983-04-19 Beecham Group Limited Tablets
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
JPS5940102B2 (ja) * 1978-11-17 1984-09-28 日本クラウンコルク株式会社 剥離可能な接着構造物
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
IT1246350B (it) * 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili

Also Published As

Publication number Publication date
ATE147623T1 (de) 1997-02-15
CZ149996A3 (en) 1996-08-14
NZ276740A (en) 1997-03-24
JP3195356B2 (ja) 2001-08-06
SK278986B6 (sk) 1998-05-06
DE69401502T2 (de) 1997-06-12
SI0693926T1 (en) 1997-10-31
DE69401502D1 (de) 1997-02-27
WO1995014462A1 (fr) 1995-06-01
RU2146518C1 (ru) 2000-03-20
CA2175470C (en) 2003-11-04
HUT75230A (en) 1997-04-28
SK63896A3 (en) 1997-04-09
CN1083260C (zh) 2002-04-24
FR2712809B1 (fr) 1996-04-12
CZ287757B6 (en) 2001-01-17
NO309024B1 (no) 2000-12-04
HU9601416D0 (en) 1996-07-29
EP0693926A1 (fr) 1996-01-31
EP0693926B1 (fr) 1997-01-15
ES2099649T3 (es) 1997-05-16
FR2712809A1 (fr) 1995-06-02
NO962129D0 (no) 1996-05-24
CA2175470A1 (en) 1995-06-01
FI116883B (fi) 2006-03-31
CN1136274A (zh) 1996-11-20
UA40636C2 (uk) 2001-08-15
GR3023074T3 (en) 1997-07-30
LV11818A (lv) 1997-08-20
AU1112395A (en) 1995-06-13
HU226895B1 (en) 2010-01-28
TW372193B (en) 1999-10-21
DK0693926T3 (da) 1997-07-14
NO962129L (no) 1996-05-24
US5437874A (en) 1995-08-01
JPH09505576A (ja) 1997-06-03
LV11818B (en) 1997-12-20
KR100351193B1 (ko) 2002-12-31
FI962056A0 (fi) 1996-05-15
AU693137B2 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
JPS55153715A (en) Prolonged granule of theophylline
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
EP0973507A4 (en) PHARMACEUTICAL FORM WHICH DELETES RAPID DISPERSION PROPERTIES, METHOD OF USE, AND METHOD FOR THE PRODUCTION THEREOF
DE60126433D1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
FI962056A (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
EP0147535A3 (en) Pharmaceutical composition comprising an e-type prostaglandin compound and useful as a topical medicament
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
IE781032L (en) Pharmaceutical compositions
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
JPS5781409A (en) External plaster
JPS5750914A (en) Betamethasone external pharmaceutical
CA2078885A1 (en) Pharmaceutical compositions containing amethocaine
DE3166825D1 (en) Process for manufacture of a coated acetylsalicylic-acid formulation
EP0362731A3 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten
ES456094A1 (es) Un procedimiento para la preparacion de 2-acetoxi-benzoato de 2-(carbamoil) fenilo.
JPS643123A (en) Remedy for skin inflammation
CA2414921A1 (en) Use of diclofenac for treatment of burns
JPS5762220A (en) Embrocation for external use
KR910015297A (ko) 오메프라졸 경구용 약제와 그 제조방법

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116883

Country of ref document: FI

MA Patent expired